Stay updated on Pimavanserin Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.
Latest updates to the Pimavanserin Relapse Prevention Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNo new additions were noted, but a significant section of content related to downloading data formats and selecting study fields has been removed.SummaryDifference14%
- Check23 days agoChange DetectedSeveral key government health and information websites have been removed from the monitored list.SummaryDifference0.7%
- Check30 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links including those to HHS, NIH, and NLM, while removing the previous version 2.12.1.SummaryDifference17%
- Check37 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.7%
Stay in the know with updates to Pimavanserin Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.